Stock 2256 ABBISKO CAYMAN LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Abbisko Cayman Limited

Equities

2256

KYG0028A1085

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:39 2024-05-28 am EDT 		5-day change 1st Jan Change
3.4 HKD +3.03% Intraday chart for Abbisko Cayman Limited -7.86% -6.85%
May. 09 Abbisko Cayman Unit's Cancer Drug To Be Clinically Tested in Combination with Shanghai Allist's Furmonertinib MT
Apr. 29 Abbisko Cayman Limited Appoints Yu Hongping as Joint Company Secretaries CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib （ABSK021）
PR
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
PR
Abbisko Therapeutics Completed Dosing of First Patient for Its First-in-Class Highly Selective FGFR2/3 Inhibitor ABSK061
PR
Abbisko Therapeutics Announces Worldwide Collaboration with Lilly to Discover and Develop Novel Molecules
PR
Abbisko Cayman : Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2256 Stock
  4. News Abbisko Cayman Limited
  5. Press Releases